MedPath

Thoracoscopic Sympathectomy for Blushing

Phase 4
Completed
Conditions
Facial Blushing
Interventions
Procedure: Level of sympathectomy
Registration Number
NCT00225069
Lead Sponsor
Odense University Hospital
Brief Summary

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.

Detailed Description

To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Isolated disabling facial blushing
  • Over 18 years of age
  • Willing to be randomized
Read More
Exclusion Criteria
  • Primary hyperhidrosis in palms or axillae
  • Previous lung surgery
  • Bradycardia
  • Arrythmias
  • Pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Level of sympathectomyT2 sympathectomy
2Level of sympathectomyT2-T3 sympathectomy
Primary Outcome Measures
NameTimeMethod
Effect of operation. Side effects: compensatory and gustatory sweating.12 months after surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Dept Cardiothoracic Surgery, Skejby Sygehus, Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Dept Cardiothorcic Surgery, Odense University Hospital

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath